{"id":"W2031152150","doi":"10.1016/j.urology.2009.12.031","title":"Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Sorafenib; Temsirolimus; Sunitinib; Everolimus; Bevacizumab; Internal medicine; Targeted therapy; Oncology; Axitinib; Vascular endothelial growth factor; Renal cell carcinoma; Cancer; Second-line therapy; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; VEGF receptors; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003585992,0.0002626797,0.0008638766,0.0006586058,0.0006949996,0.0009079523,0.0003041043,0.0006236091,0.001462813],"category_scores_gemma":[0.001924039,0.0001236818,0.0008399856,0.0008325545,0.0004177335,0.0005665122,0.0005064375,0.0006681997,0.0003384597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007237525,"about_ca_system_score_gemma":0.0004279493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002643518,"about_ca_topic_score_gemma":0.002454655,"domain_scores_codex":[0.9997001,0.00005250994,0.00002924643,0.00004343929,0.00004543269,0.000129453],"domain_scores_gemma":[0.9988759,0.0002269859,0.0002760803,0.00003126796,0.0001248526,0.0004647643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002804067,0.0001733253,0.9842514,0.00002961595,0.000140086,0.00386936,0.000145816,0.0003997048,0.0009018359,0.0000546582,0.0004216615,0.006808477],"study_design_scores_gemma":[0.00006111474,0.001497316,0.9925459,0.00001492073,0.0001271047,0.004348514,0.0002353887,0.0004656778,0.0001881587,0.0001086956,0.0003835552,0.00002368961],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976732,0.0006401179,0.00007809904,0.0001201146,0.000021076,0.000008329588,0.0002396667,0.000004588626,0.001214786],"genre_scores_gemma":[0.9991148,0.0001457095,0.00001970105,0.00004831891,0.00003629378,0.000005164078,0.0004496777,0.000001983317,0.0001782671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002643518,"threshold_uncertainty_score":0.005256295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02788989558493725,"score_gpt":0.3073046206455494,"score_spread":0.2794147250606122,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}